In some studies, APOE4 carriers showed significantly more cognitive impairment in association with adverse metabolic conditions including atherosclerosis, peripheral vascular disease, type 2 diabetes (Haan et al., 1999), and high systolic blood pressure at midlife (Peila et al., 2001). This evidence concerns the gene APOE and atherosclerosis.